🔎 Under the Radar: Kodiak Stock Surges as Eye Drug Matches Regeneron’s - WSJ

As reported by The Wall Street Journal

Shares of Kodiak Sciences surged more than 170% Monday—on pace for its largest one-day increase on record—after the company announced its eye drug matched Regeneron's blockbuster Eylea in a Phase 3 trial.Palo Alto, Calif.-based Kodiak said that more than half…

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on The Wall Street Journal ↗

Market Samachar is a news aggregator. This article was originally published by The Wall Street Journal. Tap the button above to read the full story on their site.

COMPANIES Kirloskar Oil Engines among 5 stocks with RSI trending up Stocks-Markets-Economic Times
INDIAN SIFs should be satellite holdings, not the core of portfolios: Morningstar CEO Kunal Kapoor Markets-Economic Times
COMPANIES FIIs dump telecom for 8th straight month, outflows cross Rs 32,000 crore. Are stocks set for rebound? Stocks-Markets-Economic Times
COMPANIES Bonus issue alert! Last day to buy these 2 microcap stocks for bonus share rewards. Do you own? Stocks-Markets-Economic Times
INDIAN IPO allotment today: Orient Cables, German Green among 4 issues; check status, GMP and listing date Markets-Economic Times
INDIAN China’s Repo Push Gains Ground as Legal Issues, Low Yields Drag mint - markets
INDIAN China’s Two-Speed Economy Spurs Yawning Gap Between Stocks, Yuan mint - markets
INDIAN Stock Market Today LIVE: Gift Nifty, US bond yield, crude, and gold rates hint at a relief rally for Nifty 50, Sensex mint - markets

🔎 Under the Radar: Kodiak Stock Surges as Eye Drug Matches Regeneron’s - WSJ

More from Market Samachar